Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
91,457,530
-
Share change
-
-2,183,933
-
Total reported value
-
$13,806,884,762
-
Put/Call ratio
-
76%
-
Price per share
-
$150.97
-
Number of holders
-
681
-
Value change
-
-$332,570,093
-
Number of buys
-
268
-
Number of sells
-
328
Institutional Holders of Lab Corp. of America - COM (LH) as of Q3 2017
As of 30 Sep 2017,
Lab Corp. of America - COM (LH) was held by
681 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,457,530 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Boston Partners, STATE STREET CORP, GLENVIEW CAPITAL MANAGEMENT, LLC, NORDEA INVESTMENT MANAGEMENT AB, UBS ASSET MANAGEMENT AMERICAS INC, GOLDMAN SACHS GROUP INC, IRIDIAN ASSET MANAGEMENT LLC/CT, and HealthCor Management, L.P..
This page lists
684
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.